|
|
Volumn 146, Issue 2, 2002, Pages 342-
|
|
Topical tacrolimus and pimecrolimus are not associated with skin atrophy [11]
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASCOMYCIN;
CYCLOSPORIN;
DERMATOLOGICAL AGENT;
PIMECROLIMUS;
SDZ 281 240;
TACROLIMUS;
UNCLASSIFIED DRUG;
ALOPECIA AREATA;
ATOPIC DERMATITIS;
CONTROLLED STUDY;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG DEVELOPMENT;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG PENETRATION;
DRUG SAFETY;
DRUG TOLERANCE;
HUMAN;
LETTER;
MOLECULAR WEIGHT;
NORMAL HUMAN;
PRIORITY JOURNAL;
PSORIASIS;
SKIN ATROPHY;
SKIN PENETRATION;
TOPICAL TREATMENT;
VALIDATION PROCESS;
|
|
EID: 0036208237
PISSN: 00070963
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2133.2002.4653_13.x Document Type: Letter |
|
Times cited : (9)
|
|
References (0)
|
